Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Dramatic secular changes in prognosis for kidney transplant candidates in the United States.

Schold JD, Arrigain S, Flechner SM, Augustine JJ, Sedor JR, Wee A, Goldfarb DA, Poggio ED.

Am J Transplant. 2019 Feb;19(2):414-424. doi: 10.1111/ajt.15021. Epub 2018 Aug 14.

PMID:
30019832
2.

Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.

Friedewald JJ, Kurian SM, Heilman RL, Whisenant TC, Poggio ED, Marsh C, Baliga P, Odim J, Brown MM, Ikle DN, Armstrong BD, Charette JI, Brietigam SS, Sustento-Reodica N, Zhao L, Kandpal M, Salomon DR, Abecassis MM; Clinical Trials in Organ Transplantation 08 (CTOT-08).

Am J Transplant. 2019 Jan;19(1):98-109. doi: 10.1111/ajt.15011. Epub 2018 Aug 31.

PMID:
29985559
3.

Gathering Clues to Explain the Stagnation in Living Donor Kidney Transplantation in the United States.

Schold JD, Poggio ED, Augustine JJ.

Am J Kidney Dis. 2018 May;71(5):608-610. doi: 10.1053/j.ajkd.2018.01.038. No abstract available.

PMID:
29685212
4.

Residential Area Life Expectancy: Association With Outcomes and Processes of Care for Patients With ESRD in the United States.

Schold JD, Flechner SM, Poggio ED, Augustine JJ, Goldfarb DA, Sedor JR, Buccini LD.

Am J Kidney Dis. 2018 Jul;72(1):19-29. doi: 10.1053/j.ajkd.2017.12.014. Epub 2018 Mar 7.

PMID:
29525324
5.

Establishing a Core Outcome Measure for Graft Health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop Report.

Tong A, Sautenet B, Poggio ED, Lentine KL, Oberbauer R, Mannon R, Murphy B, Padilla B, Chow KM, Marson L, Chadban S, Craig JC, Ju A, Manera KE, Hanson CS, Josephson MA, Knoll G; SONG-Tx Graft Health Workshop Investigators.

Transplantation. 2018 Aug;102(8):1358-1366. doi: 10.1097/TP.0000000000002125.

PMID:
29470347
6.

The Quest to Define Individual Risk After Living Kidney Donation.

Poggio ED, Reese PP.

Ann Intern Med. 2018 Feb 20;168(4):296-297. doi: 10.7326/M17-3249. Epub 2018 Jan 30. No abstract available.

PMID:
29379960
7.

APOL1 Genotype and Renal Function of Black Living Donors.

Doshi MD, Ortigosa-Goggins M, Garg AX, Li L, Poggio ED, Winkler CA, Kopp JB.

J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.

PMID:
29339549
8.

Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17.

Faddoul G, Nadkarni GN, Bridges ND, Goebel J, Hricik DE, Formica R, Menon MC, Morrison Y, Murphy B, Newell K, Nickerson P, Poggio ED, Rush D, Heeger PS; CTOT-17 consortium.

Transplantation. 2018 Apr;102(4):673-680. doi: 10.1097/TP.0000000000002026.

PMID:
29189482
9.

Postdonation Anemia in Living Kidney Donors.

Shah S, Lankowsky B, Gao T, Zaky Z, Stephany BR, Poggio ED.

Transplant Proc. 2017 Oct;49(8):1733-1738. doi: 10.1016/j.transproceed.2017.06.034.

PMID:
28923617
10.

Comparison of normothermic and hypothermic perfusion in porcine kidneys donated after cardiac death.

Blum MF, Liu Q, Soliman B, Dreher P, Okamoto T, Poggio ED, Goldfarb DA, Baldwin WM 3rd, Quintini C.

J Surg Res. 2017 Aug;216:35-45. doi: 10.1016/j.jss.2017.04.008. Epub 2017 Apr 20.

11.

Development of a prolonged warm ex vivo perfusion model for kidneys donated after cardiac death.

Urcuyo D, Blum MF, Liu Q, Nassar A, Buccini LD, Diago Uso T, Poggio ED, Baldwin Iii WM, Goldfarb DA, Quintini C.

Int J Artif Organs. 2017 Jun 9;40(6):265-271. doi: 10.5301/ijao.5000586. Epub 2017 May 24.

PMID:
28574105
12.

Building an Ideal Quality Metric for ESRD Health Care Delivery.

Schold JD, Buccini LD, Phelan MP, Jay CL, Goldfarb DA, Poggio ED, Sedor JR.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1351-1356. doi: 10.2215/CJN.01020117. Epub 2017 May 17. No abstract available.

13.

Synthesizing Absolute and Relative Risks and the Many Unknowns to Inform Living Kidney Donors.

Poggio ED, Schold JD.

J Am Soc Nephrol. 2017 Sep;28(9):2559-2561. doi: 10.1681/ASN.2017040375. Epub 2017 May 2. No abstract available.

14.

Cell-Free DNA and Active Rejection in Kidney Allografts.

Bloom RD, Bromberg JS, Poggio ED, Bunnapradist S, Langone AJ, Sood P, Matas AJ, Mehta S, Mannon RB, Sharfuddin A, Fischbach B, Narayanan M, Jordan SC, Cohen D, Weir MR, Hiller D, Prasad P, Woodward RN, Grskovic M, Sninsky JJ, Yee JP, Brennan DC; Circulating Donor-Derived Cell-Free DNA in Blood for Diagnosing Active Rejection in Kidney Transplant Recipients (DART) Study Investigators.

J Am Soc Nephrol. 2017 Jul;28(7):2221-2232. doi: 10.1681/ASN.2016091034. Epub 2017 Mar 9.

15.

Evaluation of Flagging Criteria of United States Kidney Transplant Center Performance: How to Best Define Outliers?

Schold JD, Miller CM, Henry ML, Buccini LD, Flechner SM, Goldfarb DA, Poggio ED, Andreoni KA.

Transplantation. 2017 Jun;101(6):1373-1380. doi: 10.1097/TP.0000000000001373.

PMID:
27482960
16.

The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging.

Denic A, Lieske JC, Chakkera HA, Poggio ED, Alexander MP, Singh P, Kremers WK, Lerman LO, Rule AD.

J Am Soc Nephrol. 2017 Jan;28(1):313-320. doi: 10.1681/ASN.2016020154. Epub 2016 Jul 8.

17.

Emergency Department Visits after Kidney Transplantation.

Schold JD, Elfadawy N, Buccini LD, Goldfarb DA, Flechner SM, P Phelan M, Poggio ED.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):674-83. doi: 10.2215/CJN.07950715. Epub 2016 Mar 24.

18.

Detection and Clinical Patterns of Nephron Hypertrophy and Nephrosclerosis Among Apparently Healthy Adults.

Denic A, Alexander MP, Kaushik V, Lerman LO, Lieske JC, Stegall MD, Larson JJ, Kremers WK, Vrtiska TJ, Chakkera HA, Poggio ED, Rule AD.

Am J Kidney Dis. 2016 Jul;68(1):58-67. doi: 10.1053/j.ajkd.2015.12.029. Epub 2016 Feb 6.

19.

Association of Candidate Removals From the Kidney Transplant Waiting List and Center Performance Oversight.

Schold JD, Buccini LD, Poggio ED, Flechner SM, Goldfarb DA.

Am J Transplant. 2016 Apr;16(4):1276-84. doi: 10.1111/ajt.13594. Epub 2016 Jan 14.

20.

Estimated GFR for Living Kidney Donor Evaluation.

Huang N, Foster MC, Lentine KL, Garg AX, Poggio ED, Kasiske BL, Inker LA, Levey AS.

Am J Transplant. 2016 Jan;16(1):171-80. doi: 10.1111/ajt.13540. Epub 2015 Nov 23.

21.

Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study.

Hricik DE, Augustine J, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Spain K, Iklé D, Bridges ND, Heeger PS; CTOT-01 consortium.

Am J Transplant. 2015 Dec;15(12):3166-73. doi: 10.1111/ajt.13401. Epub 2015 Jul 30.

22.

Living Donor Kidney Transplantation: Improving Education Outside of Transplant Centers about Live Donor Transplantation--Recommendations from a Consensus Conference.

Waterman AD, Morgievich M, Cohen DJ, Butt Z, Chakkera HA, Lindower C, Hays RE, Hiller JM, Lentine KL, Matas AJ, Poggio ED, Rees MA, Rodrigue JR, LaPointe Rudow D; American Society of Transplantation.

Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1659-69. doi: 10.2215/CJN.00950115. Epub 2015 Jun 26.

23.

Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW, Wiebe C, Tinckam K, Bunnapradist S, Samaniego-Picota M, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS; Clinical Trials in Organ Transplantation-09 Consortium.

J Am Soc Nephrol. 2015 Dec;26(12):3114-22. doi: 10.1681/ASN.2014121234. Epub 2015 Apr 29.

24.

Critical Factors Associated With Missing Follow-Up Data for Living Kidney Donors in the United States.

Schold JD, Buccini LD, Rodrigue JR, Mandelbrot D, Goldfarb DA, Flechner SM, Kayler LK, Poggio ED.

Am J Transplant. 2015 Sep;15(9):2394-403. doi: 10.1111/ajt.13282. Epub 2015 Apr 22.

25.

Distinguishing age-related from disease-related glomerulosclerosis on kidney biopsy: the Aging Kidney Anatomy study.

Kremers WK, Denic A, Lieske JC, Alexander MP, Kaushik V, Elsherbiny HE, Chakkera HA, Poggio ED, Rule AD.

Nephrol Dial Transplant. 2015 Dec;30(12):2034-9. doi: 10.1093/ndt/gfv072. Epub 2015 Apr 16.

26.

Nephron hypertrophy and glomerulosclerosis and their association with kidney function and risk factors among living kidney donors.

Elsherbiny HE, Alexander MP, Kremers WK, Park WD, Poggio ED, Prieto M, Lieske JC, Rule AD.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1892-902. doi: 10.2215/CJN.02560314. Epub 2014 Oct 15.

27.

Effect of dialysis initiation for preemptively listed candidates in the revised kidney allocation policy.

Schold JD, Buccini LD, Reese PP, Poggio ED, Goldfarb DA.

Am J Transplant. 2014 Dec;14(12):2855-60. doi: 10.1111/ajt.12957. Epub 2014 Oct 2.

28.

Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis.

Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Poggio ED, Sehgal AR.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1773-80. doi: 10.2215/CJN.02380314. Epub 2014 Sep 18.

29.

Molecular monitoring of alloimmune-mediated injury in kidney transplant patients.

Traitanon O, Poggio ED, Fairchild RL.

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):625-30. doi: 10.1097/MNH.0000000000000064. Review.

PMID:
25202838
30.

IL-15 induces alloreactive CD28(-) memory CD8 T cell proliferation and CTLA4-Ig resistant memory CD8 T cell activation.

Traitanon O, Gorbachev A, Bechtel JJ, Keslar KS, Baldwin WM 3rd, Poggio ED, Fairchild RL.

Am J Transplant. 2014 Jun;14(6):1277-89. doi: 10.1111/ajt.12719. Epub 2014 May 19.

31.

Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplant.

Heaphy EL, Poggio ED, Flechner SM, Goldfarb DA, Askar M, Fatica R, Srinivas TR, Schold JD.

Am J Transplant. 2014 Jun;14(6):1356-67. doi: 10.1111/ajt.12690. Epub 2014 Apr 14.

32.

Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients.

Shaffi K, Uhlig K, Perrone RD, Ruthazer R, Rule A, Lieske JC, Navis G, Poggio ED, Inker LA, Levey AS.

Am J Kidney Dis. 2014 Jun;63(6):1007-18. doi: 10.1053/j.ajkd.2014.01.436. Epub 2014 Apr 2.

33.

Hospitalizations following living donor nephrectomy in the United States.

Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot D, Heaphy EL, Fatica RA, Poggio ED.

Clin J Am Soc Nephrol. 2014 Feb;9(2):355-65. doi: 10.2215/CJN.03820413. Epub 2014 Jan 23.

34.

Alloreactive T cells and 'the persistence of memory'.

Poggio ED, Augustine JJ.

Kidney Int. 2013 Dec;84(6):1074-6. doi: 10.1038/ki.2013.295.

35.

Comorbidity burden and perioperative complications for living kidney donors in the United States.

Schold JD, Goldfarb DA, Buccini LD, Rodrigue JR, Mandelbrot DA, Heaphy EL, Fatica RA, Poggio ED.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1773-82. doi: 10.2215/CJN.12311212. Epub 2013 Sep 26.

36.

Prominent impact of community risk factors on kidney transplant candidate processes and outcomes.

Schold JD, Heaphy EL, Buccini LD, Poggio ED, Srinivas TR, Goldfarb DA, Flechner SM, Rodrigue JR, Thornton JD, Sehgal AR.

Am J Transplant. 2013 Sep;13(9):2374-83. doi: 10.1111/ajt.12349. Epub 2013 Aug 22.

37.

Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.

Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Riggs M, Spain K, Ikle D, Bridges ND, Heeger PS; CTOT-01 consortium.

Am J Transplant. 2013 Oct;13(10):2634-44. doi: 10.1111/ajt.12426. Epub 2013 Aug 22.

38.

Association of metabolic syndrome with kidney function and histology in living kidney donors.

Ohashi Y, Thomas G, Nurko S, Stephany B, Fatica R, Chiesa A, Rule AD, Srinivas T, Schold JD, Navaneethan SD, Poggio ED.

Am J Transplant. 2013 Sep;13(9):2342-51. doi: 10.1111/ajt.12369. Epub 2013 Jul 19.

39.

The prognostic value of kidney transplant center report cards.

Schold JD, Buccini LD, Heaphy EL, Goldfarb DA, Sehgal AR, Fung J, Poggio ED, Kattan MW.

Am J Transplant. 2013 Jul;13(7):1703-12. doi: 10.1111/ajt.12294. Epub 2013 May 24.

40.

Effects of cellular sensitization and donor age on acute rejection and graft function after deceased-donor kidney transplantation.

Hricik DE, Poggio ED, Woodside KJ, Sarabu N, Sanchez EQ, Schulak JA, Padiyar A, Heeger PS, Augustine JJ.

Transplantation. 2013 May 27;95(10):1254-8. doi: 10.1097/TP.0b013e31828ad866.

41.

Metabolic syndrome, ESRD, and death in CKD.

Navaneethan SD, Schold JD, Kirwan JP, Arrigain S, Jolly SE, Poggio ED, Beddhu S, Nally JV Jr.

Clin J Am Soc Nephrol. 2013 Jun;8(6):945-52. doi: 10.2215/CJN.09870912. Epub 2013 Feb 14.

42.

The impact of deceased donor kidney risk significantly varies by recipient characteristics.

Heaphy ELG, Goldfarb DA, Poggio ED, Buccini LD, Flechner SM, Schold JD.

Am J Transplant. 2013 Apr;13(4):1001-1011. doi: 10.1111/ajt.12154. Epub 2013 Feb 13.

43.

The association of center performance evaluations and kidney transplant volume in the United States.

Schold JD, Buccini LD, Srinivas TR, Srinivas RT, Poggio ED, Flechner SM, Soria C, Segev DL, Fung J, Goldfarb DA.

Am J Transplant. 2013 Jan;13(1):67-75. doi: 10.1111/j.1600-6143.2012.04345.x.

44.

Do living kidney donors have CKD?

Srinivas TR, Poggio ED.

Adv Chronic Kidney Dis. 2012 Jul;19(4):229-36. doi: 10.1053/j.ackd.2012.05.008. Review.

PMID:
22732042
45.

Serum triglycerides and risk for death in Stage 3 and Stage 4 chronic kidney disease.

Navaneethan SD, Schold JD, Arrigain S, Thomas G, Jolly SE, Poggio ED, Schreiber MJ Jr, Sarnak MJ, Nally JV Jr.

Nephrol Dial Transplant. 2012 Aug;27(8):3228-34. doi: 10.1093/ndt/gfs058. Epub 2012 May 2.

46.

The association of community health indicators with outcomes for kidney transplant recipients in the United States.

Schold JD, Buccini LD, Kattan MW, Goldfarb DA, Flechner SM, Srinivas TR, Poggio ED, Fatica R, Kayler LK, Sehgal AR.

Arch Surg. 2012 Jun;147(6):520-6. doi: 10.1001/archsurg.2011.2220.

47.

Critical care: estimating renal function in the ICU: even more challenging.

Demirjian S, Poggio ED.

Nat Rev Nephrol. 2011 Sep 6;7(10):549-50. doi: 10.1038/nrneph.2011.126. No abstract available.

PMID:
21894185
48.

Senile nephrosclerosis--does it explain the decline in glomerular filtration rate with aging?

Rule AD, Cornell LD, Poggio ED.

Nephron Physiol. 2011;119 Suppl 1:p6-11. doi: 10.1159/000328012. Epub 2011 Aug 10. Review.

49.

Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker.

Cherkassky L, Lanning M, Lalli PN, Czerr J, Siegel H, Danziger-Isakov L, Srinivas T, Valujskikh A, Shoskes DA, Baldwin W, Fairchild RL, Poggio ED.

Am J Transplant. 2011 Jul;11(7):1388-96. doi: 10.1111/j.1600-6143.2011.03540.x. Epub 2011 May 12.

50.

A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation.

Hall IE, Doshi MD, Poggio ED, Parikh CR.

Transplantation. 2011 Jan 15;91(1):48-56. doi: 10.1097/TP.0b013e3181fc4b3a.

PMID:
21441853

Supplemental Content

Loading ...
Support Center